XML 84 R78.htm IDEA: XBRL DOCUMENT v3.25.3
Restructuring - Summary of Charges Incurred by the Company in Connection with the Bruker Cellular Analysis Restructuring Plan (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 34.5 $ 4.3 $ 52.0 $ 17.6
Severance and Termination Charges        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 3.8   3.8  
BCA Restructuring Program        
Restructuring Cost and Reserve [Line Items]        
Impairment charge against operating lease right of use assets 0.0 1.5 0.0 1.5
BCA Restructuring Program | Severance and Termination Charges        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges [1] 0.0 1.2 1.2 7.8
BCA Restructuring Program | Product Restructuring Costs        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 0.0 $ 4.7 $ 0.0 $ 4.7
[1] The Company made no severance payments during the three months ended September 30, 2025 and made severance payments of $3.7 million for the nine months ended September 30, 2025. The Company made severance payments of $2.8 million and $13.5 million during the three and nine months ended September 30, 2024, respectively.